A new score predicting the survival of patients with spinal cord compression from myeloma

BMC Cancer

Table 1 Test group: Univariate analysis of pre-treatment factors and the radiation regimen for survival

	Survival at 6 months (%)	Survival at 12 months (%)	Median survival time (months)	p-value
Age
≤ 63 years	82	76	45
≥ 64 years	88	73	57	0.92
Gender
i Female	76	61	37
Male	90	83	45	0.29
ECOG Performance status
1-2	91	81	57
3-4	73	60	14	0.006
Number of involved vertebrae
1-2	83	73	70
≥ 3	87	77	37	0.95
Ambulatory status prior to radiotherapy
Not Ambulatory	70	56	14
Ambulatory before RT	90	81	57	0.005
Other bone lesions
No	98	84	not reached
Yes	76	69	32	0.019
Extraosseous lesions
No	86	75	45
Yes	67	not available	not available	0.35
Interval from cancer diagnosis to radiotherapy of MSCC
≤ 15 months	90	77	45
> 15 months	80	73	32	0.19
Time developing motor deficits
1-14 days	80	66	19
> 14 days	89	81	57	0.27
Radiation regimen
Short-course radiotherapy	81	72	45
Longer-course radiotherapy	87	76	57	0.97

ISSN: 1471-2407